Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
Reqorsa (quaratusugene ozeplasmid)
i
Other names:
GPX-001, DOTAP:Chol-TUSC2, DOTAP:cholesterol-TUSC2 liposome complex, CNVN202, INGN 401
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(3)
News
Trials
Company:
Genprex
Drug class:
Apoptosis stimulant, Immunomodulator, Gene transference, TUSC2 gene stimulant
Related drugs:
‹
lurbinectedin (11)
arsenic trioxide (6)
STA-4783 (5)
pelareorep (4)
omacetaxine mepesuccinate (4)
GZ17-6.02 (3)
BAL101553 (3)
teserpaturev (1)
IT-141 (1)
Alpha1H (1)
NEO100 (1)
ABI-1968 topical cream (0)
APTO-253 (0)
BP-C1 (0)
BXQ-350 (0)
CM-728 (0)
IL-17E (0)
autologous γδ T lymphocytes (0)
KLTi (0)
MT-3724 (0)
84AA-API 14AA (0)
PVT-1 (0)
SVV-001 (0)
alpha-tocopheroloxyacetic acid (0)
darinaparsin (0)
AFP-464 (0)
elemene injection (0)
BAY1862864 (0)
BS-HH-002.SA (0)
PT-112 (0)
K-333 (0)
piceatannol (0)
AP1903 (0)
PRX302 (0)
hydroxychloroquine (7)
CMP-001 (3)
Orca-T (1)
SQZ-AAC-HPV (1)
SV-102 (1)
MAM-06.301 (1)
ABV-1501 (0)
ALT-801 (0)
ATA520 (0)
HLA-matched donor mononuclear enriched leukocytes (0)
BMS-986242 (0)
CEP-37250 (0)
CK0801 (0)
CO-1002 (0)
rimiducid activated rivogenlecleucel (0)
CyPep-1 (0)
GB221 (trastuzumab biosimilar) (0)
GSK2302024A (0)
Ganfule (0)
IMCnyeso (0)
KFA115 (0)
MVA-BN-HER2 (0)
NOV-002 (0)
nelipepimut-S (0)
ORB-011 (0)
engineered donor allograft cell therapy (0)
parvovirus H-1 (0)
FT1050+FT4145 programmed mPB (0)
allodepleted T-cell immunotherapeutics (0)
SER-401 (0)
SI-101 (0)
ScTIL (0)
ScTIL210 (0)
TAEK-VAC-HerBy vaccine (0)
TAK-012 (0)
TST010 (0)
Undisclosed CISH inactivated TIL (0)
WTX212 (0)
SB-313 (0)
thymalfasin (0)
BAZE-X1 (0)
chlorogenic acid (0)
dendritic cell activation therapy (0)
DVX101 (0)
hV01 (0)
minocycline (0)
EC-18 (0)
HF1K16 (0)
oral rhLF (0)
aglatimagene besadenovec (6)
AdCD40L (0)
retroviral expression vectors bearing inhibitory genes (0)
E7 TCR cells (0)
GZ402663 (0)
LPX EWS/FL1 T1 (0)
EG-70 (0)
BC 819 (0)
rAAV2tYF-PR1.7-hCNGB3 (0)
lurbinectedin (11)
arsenic trioxide (6)
STA-4783 (5)
pelareorep (4)
omacetaxine mepesuccinate (4)
GZ17-6.02 (3)
BAL101553 (3)
teserpaturev (1)
IT-141 (1)
Alpha1H (1)
NEO100 (1)
ABI-1968 topical cream (0)
APTO-253 (0)
BP-C1 (0)
BXQ-350 (0)
CM-728 (0)
IL-17E (0)
autologous γδ T lymphocytes (0)
KLTi (0)
MT-3724 (0)
84AA-API 14AA (0)
PVT-1 (0)
SVV-001 (0)
alpha-tocopheroloxyacetic acid (0)
darinaparsin (0)
AFP-464 (0)
elemene injection (0)
BAY1862864 (0)
BS-HH-002.SA (0)
PT-112 (0)
K-333 (0)
piceatannol (0)
AP1903 (0)
PRX302 (0)
hydroxychloroquine (7)
CMP-001 (3)
Orca-T (1)
SQZ-AAC-HPV (1)
SV-102 (1)
MAM-06.301 (1)
ABV-1501 (0)
ALT-801 (0)
ATA520 (0)
HLA-matched donor mononuclear enriched leukocytes (0)
BMS-986242 (0)
CEP-37250 (0)
CK0801 (0)
CO-1002 (0)
rimiducid activated rivogenlecleucel (0)
CyPep-1 (0)
GB221 (trastuzumab biosimilar) (0)
GSK2302024A (0)
Ganfule (0)
IMCnyeso (0)
KFA115 (0)
MVA-BN-HER2 (0)
NOV-002 (0)
nelipepimut-S (0)
ORB-011 (0)
engineered donor allograft cell therapy (0)
parvovirus H-1 (0)
FT1050+FT4145 programmed mPB (0)
allodepleted T-cell immunotherapeutics (0)
SER-401 (0)
SI-101 (0)
ScTIL (0)
ScTIL210 (0)
TAEK-VAC-HerBy vaccine (0)
TAK-012 (0)
TST010 (0)
Undisclosed CISH inactivated TIL (0)
WTX212 (0)
SB-313 (0)
thymalfasin (0)
BAZE-X1 (0)
chlorogenic acid (0)
dendritic cell activation therapy (0)
DVX101 (0)
hV01 (0)
minocycline (0)
EC-18 (0)
HF1K16 (0)
oral rhLF (0)
aglatimagene besadenovec (6)
AdCD40L (0)
retroviral expression vectors bearing inhibitory genes (0)
E7 TCR cells (0)
GZ402663 (0)
LPX EWS/FL1 T1 (0)
EG-70 (0)
BC 819 (0)
rAAV2tYF-PR1.7-hCNGB3 (0)
›
Associations
(3)
News
Trials
VERI cancer hierarchy
Reset Filters
No biomarker
Non Small Cell Lung Cancer
No biomarker
Non Small Cell Lung Cancer
pembrolizumab + quaratusugene ozeplasmid
Sensitive: B - Late Trials
pembrolizumab + quaratusugene ozeplasmid
Sensitive
:
B
pembrolizumab + quaratusugene ozeplasmid
Sensitive: B - Late Trials
pembrolizumab + quaratusugene ozeplasmid
Sensitive
:
B
No biomarker
Small Cell Lung Cancer
No biomarker
Small Cell Lung Cancer
atezolizumab + quaratusugene ozeplasmid
Sensitive: B - Late Trials
atezolizumab + quaratusugene ozeplasmid
Sensitive
:
B
atezolizumab + quaratusugene ozeplasmid
Sensitive: B - Late Trials
atezolizumab + quaratusugene ozeplasmid
Sensitive
:
B
KRAS mutation + STK11 mutation
Non Small Cell Lung Cancer
KRAS mutation + STK11 mutation
Non Small Cell Lung Cancer
pembrolizumab + quaratusugene ozeplasmid
Sensitive: D – Preclinical
pembrolizumab + quaratusugene ozeplasmid
Sensitive
:
D
pembrolizumab + quaratusugene ozeplasmid
Sensitive: D – Preclinical
pembrolizumab + quaratusugene ozeplasmid
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login